PathwayTMB: A pathway-based tumor mutational burden analysis method for predicting the clinical outcome of cancer immunotherapy

• Auteurs principaux: Xiangmei Li (Auteur), Yalan He (Auteur), Ying Jiang (Auteur), Bingyue Pan (Auteur), Jiashuo Wu (Auteur), Xilong Zhao (Auteur), Junling Huang (Auteur), Qian Wang (Auteur), Liang Cheng (Auteur), Junwei Han (Auteur)
• Format: Livre
• Publié: Elsevier, 2023-12-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Immunotherapy has become one of the most promising therapy methods for cancer, but only a small number of patients are responsive to it, indicating that more effective biomarkers are urgently needed. This study developed a pathway analysis method, named PathwayTMB, to identify genomic mutation pathw...